Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Multiple Sclerosis

  Free Subscription

Articles published in J Clin Invest

Retrieve available abstracts of 8 articles:
HTML format
Text format

Single Articles

    November 2017
  1. DE FEO D, Merlini A, Brambilla E, Ottoboni L, et al
    Neural precursor cell-secreted TGF-beta2 redirects inflammatory monocyte-derived cells in CNS autoimmunity.
    J Clin Invest. 2017;127:3937-3953.
    PubMed     Text format     Abstract available

    October 2017
  2. CHITNIS T, Weiner HL
    CNS inflammation and neurodegeneration.
    J Clin Invest. 2017;127:3577-3587.
    PubMed     Text format     Abstract available

  3. LI B, Wang X, Choi IY, Wang YC, et al
    miR-146a modulates autoreactive Th17 cell differentiation and regulates organ-specific autoimmunity.
    J Clin Invest. 2017;127:3702-3716.
    PubMed     Text format     Abstract available

    September 2017
  4. PHILIPS T, Rothstein JD
    Oligodendroglia: metabolic supporters of neurons.
    J Clin Invest. 2017;127:3271-3280.
    PubMed     Text format     Abstract available

  5. KURODA M, Muramatsu R, Maedera N, Koyama Y, et al
    Peripherally derived FGF21 promotes remyelination in the central nervous system.
    J Clin Invest. 2017;127:3496-3509.
    PubMed     Text format     Abstract available

    August 2017
  6. HORNG S, Therattil A, Moyon S, Gordon A, et al
    Astrocytic tight junctions control inflammatory CNS lesion pathogenesis.
    J Clin Invest. 2017;127:3136-3151.
    PubMed     Text format     Abstract available

    June 2016
  7. ABSINTA M, Sati P, Schindler M, Leibovitch EC, et al
    Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions.
    J Clin Invest. 2016 Jun 6. pii: 86198. doi: 10.1172/JCI86198.
    PubMed     Text format     Abstract available

    April 2015
  8. PROIA RL, Hla T
    Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy.
    J Clin Invest. 2015;125:1379-87.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.